Renaissance Technologies’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-66,795
| Closed | -$218K | – | 4589 |
|
|
2022
Q4 | $218K | Sell |
66,795
-47,760
| -42% | -$114K | ﹤0.01% | 3379 |
|
|
2022
Q3 | $337K | Buy |
114,555
+13,855
| +14% | +$47.4K | ﹤0.01% | 3155 |
|
|
2022
Q2 | $248K | Buy |
100,700
+8,025
| +9% | +$37.2K | ﹤0.01% | 3554 |
|
|
2022
Q1 | $749K | Buy |
92,675
+24,805
| +37% | +$253K | ﹤0.01% | 2916 |
|
|
2021
Q4 | $903K | Buy |
67,870
+48,940
| +259% | +$1.23M | ﹤0.01% | 2722 |
|
|
2021
Q3 | $825K | Sell |
18,930
-17,324
| -48% | -$747K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $1.51M | Buy |
36,254
+8,211
| +29% | +$361K | ﹤0.01% | 2432 |
|
|
2021
Q1 | $1.36M | Buy |
28,043
+12,048
| +75% | +$701K | ﹤0.01% | 2459 |
|
|
2020
Q4 | $1.57M | Sell |
15,995
-41,921
| -72% | -$3.67M | ﹤0.01% | 2270 |
|
|
2020
Q3 | $4M | Buy |
57,916
+5,160
| +10% | +$450K | ﹤0.01% | 1702 |
|
|
2020
Q2 | $5.57M | Sell |
52,756
-2,748
| -5% | -$326K | ﹤0.01% | 1568 |
|
|
2020
Q1 | $4.93M | Sell |
55,504
-4,647
| -8% | -$554K | ﹤0.01% | 1573 |
|
|
2019
Q4 | $6.87M | Buy |
60,151
+6,211
| +12% | +$467K | 0.01% | 1676 |
|
|
2019
Q3 | $3.33M | Buy |
53,940
+16,430
| +44% | +$1.32M | ﹤0.01% | 2021 |
|
|
2019
Q2 | $2.93M | Buy |
37,510
+13,000
| +53% | +$1.48M | ﹤0.01% | 2130 |
|
|
2019
Q1 | $3.3M | Buy |
24,510
+11,545
| +89% | +$1.21M | ﹤0.01% | 2058 |
|
|
2018
Q4 | $1.04M | Buy |
12,965
+11,786
| +1,000% | +$1.16M | ﹤0.01% | 2552 |
|
|
2018
Q3 | $124K | Sell |
1,179
-6,901
| -85% | -$657K | ﹤0.01% | 3224 |
|
|
2018
Q2 | $808K | Sell |
8,080
-5,415
| -40% | -$613K | ﹤0.01% | 2684 |
|
|
2018
Q1 | $1.7M | Sell |
13,495
-8,153
| -38% | -$1.27M | ﹤0.01% | 2410 |
|
|
2017
Q4 | $3.62M | Buy |
21,648
+13,673
| +171% | +$3.5M | ﹤0.01% | 2005 |
|
|
2017
Q3 | $2.51M | Buy |
+7,975
| New | +$2.52M | ﹤0.01% | 2175 |
|
|
2016
Q4 | – | Sell |
-4,622
| Closed | -$300K | – | 3546 |
|
|
2016
Q3 | $300K | Buy |
+4,622
| New | +$298K | ﹤0.01% | 2962 |
|
Other funds holding CALA
Renaissance Technologies's CALA Position: Q1 2023 in Review
Renaissance Technologies sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 66,795 shares — an estimated $218K sold.
Renaissance Technologies first reported a position in CALA in Q3 2016 and held it in 23 quarters. The position peaked at $6.87M in Q4 2019. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Renaissance Technologies reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Renaissance Technologies sold 66,795 Calithera Biosciences, Inc shares in Q1 2023, an estimated $218K.
- Renaissance Technologies first reported a position in Calithera Biosciences, Inc in Q3 2016 and held it in 23 quarters.
- Renaissance Technologies's Calithera Biosciences, Inc position peaked at $6.87M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.